Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Wright

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|January 21, 2006
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humansPeter F Wright, Ruth A Karron, Shabir A Madhi, et al.
The Journal of Infectious Diseases|January 3, 2006
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experienceJohn V Williams, Chiaoyin K Wang, Chin-Fen Yang, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needsRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United StatesAudrey Godin, Ruth I Connor, Hanna N Degefu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2021
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized SpikeAndrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
Elife|March 15, 2022
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spikeAndrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
The Journal of Infectious Diseases|November 20, 2004
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young childrenRobert B Belshe, Frances K Newman, Edwin L Anderson, et al.
Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|January 21, 2006
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humansPeter F Wright, Ruth A Karron, Shabir A Madhi, et al.
The Journal of Infectious Diseases|January 3, 2006
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experienceJohn V Williams, Chiaoyin K Wang, Chin-Fen Yang, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needsRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United StatesAudrey Godin, Ruth I Connor, Hanna N Degefu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2021
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized SpikeAndrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
Elife|March 15, 2022
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spikeAndrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
The Journal of Infectious Diseases|November 20, 2004
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young childrenRobert B Belshe, Frances K Newman, Edwin L Anderson, et al.
Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Pageof 16